Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2021 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations

SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...
February 03, 2021 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients

SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...
September 30, 2020 09:00 ET | Source: Content Marketing Institute

New Research Details How B2B Content Marketers are Responding to COVID-19

NEW YORK, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Content Marketing Institute (CMI) just released its 11th annual B2B content marketing research report which includes insights into how content marketers...
June 09, 2020 08:30 ET | Source: Multiverse Investment Fund I, LP

Multiverse Investment Fund Announces Portfolio Company’s Participation in Coronavirus Vaccine Development

LOS ANGELES, June 09, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Multiverse Investment Fund I, LP, a private venture capital fund dedicated to long-term capital investment in companies offering...
April 15, 2020 08:30 ET | Source: Multiverse Investment Fund I, LP

Multiverse Investment Fund Announces Portfolio Company’s Commencement of Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19)

Multiverse Investment Fund Portfolio Company Begins Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19) ARDS has been identified as the leading cause...